

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.03255987 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.03255987 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.94680920 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.79430685 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.77596078 |
| 6 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.39597640 |
| 7 | positive regulation of B cell differentiation (GO:0045579) | 4.70514091 |
| 8 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.68270071 |
| 9 | B cell receptor signaling pathway (GO:0050853) | 4.63987749 |
| 10 | regulation of B cell differentiation (GO:0045577) | 4.58119032 |
| 11 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.46382821 |
| 12 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.39035447 |
| 13 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.32476235 |
| 14 | negative regulation of phagocytosis (GO:0050765) | 4.04771716 |
| 15 | regulation of gamma-delta T cell activation (GO:0046643) | 3.99605874 |
| 16 | response to peptidoglycan (GO:0032494) | 3.97759146 |
| 17 | immunoglobulin mediated immune response (GO:0016064) | 3.76137334 |
| 18 | detection of other organism (GO:0098543) | 3.64514110 |
| 19 | positive thymic T cell selection (GO:0045059) | 3.58071356 |
| 20 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.55348101 |
| 21 | barbed-end actin filament capping (GO:0051016) | 3.53481530 |
| 22 | detection of bacterium (GO:0016045) | 3.53187790 |
| 23 | regulation of mast cell degranulation (GO:0043304) | 3.47774189 |
| 24 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.45608166 |
| 25 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.44570584 |
| 26 | detection of molecule of bacterial origin (GO:0032490) | 3.42994683 |
| 27 | defense response to protozoan (GO:0042832) | 3.41025645 |
| 28 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.39174673 |
| 29 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.39174673 |
| 30 | modulation by symbiont of host immune response (GO:0052553) | 3.39174673 |
| 31 | positive regulation by symbiont of host defense response (GO:0052509) | 3.39174673 |
| 32 | modulation by symbiont of host defense response (GO:0052031) | 3.39174673 |
| 33 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.39174673 |
| 34 | detection of external biotic stimulus (GO:0098581) | 3.38872098 |
| 35 | mature B cell differentiation (GO:0002335) | 3.35183313 |
| 36 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.34992020 |
| 37 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.34717554 |
| 38 | negative regulation of cell killing (GO:0031342) | 3.34717554 |
| 39 | definitive hemopoiesis (GO:0060216) | 3.33313969 |
| 40 | positive regulation of interferon-alpha production (GO:0032727) | 3.30658895 |
| 41 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.29668711 |
| 42 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.28221667 |
| 43 | tolerance induction (GO:0002507) | 3.28023382 |
| 44 | response to protozoan (GO:0001562) | 3.21967977 |
| 45 | myeloid dendritic cell activation (GO:0001773) | 3.21685555 |
| 46 | negative thymic T cell selection (GO:0045060) | 3.21322684 |
| 47 | regulation of interferon-alpha production (GO:0032647) | 3.18734814 |
| 48 | granulocyte activation (GO:0036230) | 3.16943847 |
| 49 | ribosomal small subunit assembly (GO:0000028) | 3.16496151 |
| 50 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.16156972 |
| 51 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.15654594 |
| 52 | negative regulation of interleukin-12 production (GO:0032695) | 3.15369228 |
| 53 | response to interleukin-15 (GO:0070672) | 3.14742741 |
| 54 | negative regulation of granulocyte differentiation (GO:0030853) | 3.14215141 |
| 55 | regulation of leukocyte degranulation (GO:0043300) | 3.13903406 |
| 56 | neutrophil activation (GO:0042119) | 3.12214433 |
| 57 | negative T cell selection (GO:0043383) | 3.11490427 |
| 58 | cellular response to zinc ion (GO:0071294) | 3.10242304 |
| 59 | T cell homeostasis (GO:0043029) | 3.08921483 |
| 60 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.08819303 |
| 61 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.07930089 |
| 62 | B cell mediated immunity (GO:0019724) | 3.06411434 |
| 63 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.06021917 |
| 64 | pinocytosis (GO:0006907) | 3.05815121 |
| 65 | megakaryocyte development (GO:0035855) | 3.05675085 |
| 66 | viral transcription (GO:0019083) | 3.04465390 |
| 67 | myeloid cell activation involved in immune response (GO:0002275) | 3.02337819 |
| 68 | mature B cell differentiation involved in immune response (GO:0002313) | 2.99051652 |
| 69 | myeloid dendritic cell differentiation (GO:0043011) | 2.98441012 |
| 70 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.98323277 |
| 71 | thymic T cell selection (GO:0045061) | 2.97566664 |
| 72 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.97394894 |
| 73 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.96750343 |
| 74 | germinal center formation (GO:0002467) | 2.95622577 |
| 75 | NIK/NF-kappaB signaling (GO:0038061) | 2.94377154 |
| 76 | positive regulation of mast cell activation (GO:0033005) | 2.93392842 |
| 77 | detection of biotic stimulus (GO:0009595) | 2.91155083 |
| 78 | response to type I interferon (GO:0034340) | 2.89142371 |
| 79 | positive regulation of antigen processing and presentation (GO:0002579) | 2.88016217 |
| 80 | lymphocyte homeostasis (GO:0002260) | 2.87337388 |
| 81 | interferon-gamma production (GO:0032609) | 2.86345648 |
| 82 | translational termination (GO:0006415) | 2.84445195 |
| 83 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.84123022 |
| 84 | regulation of mast cell activation (GO:0033003) | 2.83943838 |
| 85 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.83478712 |
| 86 | cellular response to type I interferon (GO:0071357) | 2.82890009 |
| 87 | type I interferon signaling pathway (GO:0060337) | 2.82890009 |
| 88 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.82825205 |
| 89 | response to interferon-alpha (GO:0035455) | 2.82531527 |
| 90 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.82112334 |
| 91 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.81499014 |
| 92 | regulation of tolerance induction (GO:0002643) | 2.81211739 |
| 93 | amino sugar catabolic process (GO:0046348) | 2.80786006 |
| 94 | T cell migration (GO:0072678) | 2.80294616 |
| 95 | negative regulation of stress fiber assembly (GO:0051497) | 2.80079614 |
| 96 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.79088373 |
| 97 | regulation of erythrocyte differentiation (GO:0045646) | 2.78525874 |
| 98 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.78281505 |
| 99 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.78255927 |
| 100 | negative regulation of innate immune response (GO:0045824) | 2.78123880 |
| 101 | macrophage activation involved in immune response (GO:0002281) | 2.77914599 |
| 102 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.77638598 |
| 103 | lymph node development (GO:0048535) | 2.76740004 |
| 104 | dendritic cell differentiation (GO:0097028) | 2.76713927 |
| 105 | regulation of macrophage chemotaxis (GO:0010758) | 2.76207419 |
| 106 | regulation of monocyte chemotaxis (GO:0090025) | 2.75988144 |
| 107 | positive regulation of lamellipodium assembly (GO:0010592) | 2.74853374 |
| 108 | negative regulation of B cell proliferation (GO:0030889) | 2.73512640 |
| 109 | regulation of mononuclear cell migration (GO:0071675) | 2.73457038 |
| 110 | neutrophil activation involved in immune response (GO:0002283) | 2.73448045 |
| 111 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.73405789 |
| 112 | positive regulation of mast cell degranulation (GO:0043306) | 2.73405789 |
| 113 | T cell selection (GO:0045058) | 2.71292655 |
| 114 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.70446556 |
| 115 | B cell homeostasis (GO:0001782) | 2.69623547 |
| 116 | respiratory burst (GO:0045730) | 2.68765820 |
| 117 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.68717788 |
| 118 | angiogenesis involved in wound healing (GO:0060055) | 2.67627975 |
| 119 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.67519675 |
| 120 | lymphocyte chemotaxis (GO:0048247) | 2.67231740 |
| 121 | response to laminar fluid shear stress (GO:0034616) | 2.67050927 |
| 122 | leukocyte aggregation (GO:0070486) | 2.66863380 |
| 123 | regulation of T cell tolerance induction (GO:0002664) | 2.66702249 |
| 124 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.66629482 |
| 125 | cellular extravasation (GO:0045123) | 2.66587997 |
| 126 | response to host immune response (GO:0052572) | 2.66557728 |
| 127 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.66557728 |
| 128 | cellular response to interleukin-15 (GO:0071350) | 2.66072535 |
| 129 | response to muramyl dipeptide (GO:0032495) | 2.65876105 |
| 130 | negative regulation of T cell mediated immunity (GO:0002710) | 2.64873851 |
| 131 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.64114620 |
| 132 | mast cell activation (GO:0045576) | 2.63528010 |
| 133 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.63421174 |
| 134 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.63294317 |
| 135 | regulation of macrophage cytokine production (GO:0010935) | 2.63010838 |
| 136 | macrophage activation (GO:0042116) | 2.61997492 |
| 137 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.61671516 |
| 138 | response to host (GO:0075136) | 2.61431147 |
| 139 | response to host defenses (GO:0052200) | 2.61431147 |
| 140 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.61431147 |
| 141 | positive regulation of histone deacetylation (GO:0031065) | 2.60793987 |
| 142 | germ cell migration (GO:0008354) | 2.60631582 |
| 143 | actin nucleation (GO:0045010) | 2.60418296 |
| 144 | regulation of antigen processing and presentation (GO:0002577) | 2.60116001 |
| 145 | mannose metabolic process (GO:0006013) | 2.58030676 |
| 146 | embryonic hemopoiesis (GO:0035162) | 2.57691530 |
| 147 | regulation of lymphocyte migration (GO:2000401) | 2.57042004 |
| 148 | leukocyte homeostasis (GO:0001776) | 2.56870841 |
| 149 | regulation of granulocyte differentiation (GO:0030852) | 2.56217906 |
| 150 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.54179934 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.89742102 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.90850265 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.72365942 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.66376703 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.51465754 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.48648526 |
| 7 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.46172701 |
| 8 | MYC_22102868_ChIP-Seq_BL_Human | 3.29546258 |
| 9 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.20630773 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.13623881 |
| 11 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.96616029 |
| 12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.87505916 |
| 13 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.77618723 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.72855269 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.67548231 |
| 16 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.63036461 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.51957837 |
| 18 | MAF_26560356_Chip-Seq_TH1_Human | 2.48193464 |
| 19 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.45781241 |
| 20 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.41806063 |
| 21 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.41185830 |
| 22 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.37946728 |
| 23 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.37165421 |
| 24 | MYB_26560356_Chip-Seq_TH2_Human | 2.31961757 |
| 25 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.31112871 |
| 26 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.23715001 |
| 27 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.22387527 |
| 28 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.21923122 |
| 29 | MYB_26560356_Chip-Seq_TH1_Human | 2.19403854 |
| 30 | UTX_26944678_Chip-Seq_JUKART_Human | 2.19194946 |
| 31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.16571196 |
| 32 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.16212678 |
| 33 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.15752393 |
| 34 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.12254723 |
| 35 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.09921401 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.07999242 |
| 37 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.04857433 |
| 38 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.98272334 |
| 39 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.93756849 |
| 40 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85806378 |
| 41 | SPI1_23127762_ChIP-Seq_K562_Human | 1.85156412 |
| 42 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82905774 |
| 43 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.82337163 |
| 44 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.80748401 |
| 45 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.71044074 |
| 46 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.62974483 |
| 47 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.62711769 |
| 48 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62622872 |
| 49 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.62458166 |
| 50 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.61983845 |
| 51 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.59374528 |
| 52 | GATA1_22025678_ChIP-Seq_K562_Human | 1.58544955 |
| 53 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58156683 |
| 54 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.52270487 |
| 55 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.50478553 |
| 56 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.49325593 |
| 57 | * MAF_26560356_Chip-Seq_TH2_Human | 1.48375216 |
| 58 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.42122191 |
| 59 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.42091056 |
| 60 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.41471177 |
| 61 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.40375138 |
| 62 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.39725331 |
| 63 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.38744449 |
| 64 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.36617358 |
| 65 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.35657303 |
| 66 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.35555259 |
| 67 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.34092019 |
| 68 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.31530474 |
| 69 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.31487520 |
| 70 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.30391268 |
| 71 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.29489427 |
| 72 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29095828 |
| 73 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.25145774 |
| 74 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.21619685 |
| 75 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.20234899 |
| 76 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.18337592 |
| 77 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.15631727 |
| 78 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12447220 |
| 79 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11731673 |
| 80 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.11642252 |
| 81 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.11368604 |
| 82 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.11093204 |
| 83 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.10063670 |
| 84 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08502487 |
| 85 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07313921 |
| 86 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.07100097 |
| 87 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.06785150 |
| 88 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06119407 |
| 89 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04568995 |
| 90 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.04476295 |
| 91 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.02236241 |
| 92 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.01893958 |
| 93 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.01254358 |
| 94 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01000595 |
| 95 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99994796 |
| 96 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.98850695 |
| 97 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.98233047 |
| 98 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.96987128 |
| 99 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.94727826 |
| 100 | P68_20966046_ChIP-Seq_HELA_Human | 0.93127993 |
| 101 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.92722452 |
| 102 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89647919 |
| 103 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.89364483 |
| 104 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.89356122 |
| 105 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89108681 |
| 106 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.88340480 |
| 107 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88311137 |
| 108 | GATA3_26560356_Chip-Seq_TH2_Human | 0.88141402 |
| 109 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.87479163 |
| 110 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.86919468 |
| 111 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.86833223 |
| 112 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86127840 |
| 113 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84293240 |
| 114 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.82533146 |
| 115 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.81405236 |
| 116 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.80495621 |
| 117 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.80236773 |
| 118 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79508412 |
| 119 | GATA1_19941826_ChIP-Seq_K562_Human | 0.78232557 |
| 120 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.77571335 |
| 121 | GATA2_19941826_ChIP-Seq_K562_Human | 0.77280223 |
| 122 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.76504419 |
| 123 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.76162020 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.99618580 |
| 2 | MP0000685_abnormal_immune_system | 3.19456322 |
| 3 | MP0001800_abnormal_humoral_immune | 3.02996507 |
| 4 | MP0001790_abnormal_immune_system | 2.90086985 |
| 5 | MP0005387_immune_system_phenotype | 2.90086985 |
| 6 | MP0002396_abnormal_hematopoietic_system | 2.86264916 |
| 7 | MP0003303_peritoneal_inflammation | 2.81950376 |
| 8 | MP0005671_abnormal_response_to | 2.78510446 |
| 9 | MP0002452_abnormal_antigen_presenting | 2.68547108 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.63307718 |
| 11 | MP0003436_decreased_susceptibility_to | 2.55129031 |
| 12 | MP0002723_abnormal_immune_serum | 2.42652333 |
| 13 | MP0003300_gastrointestinal_ulcer | 2.41104806 |
| 14 | MP0002420_abnormal_adaptive_immunity | 2.39763186 |
| 15 | MP0001819_abnormal_immune_cell | 2.35785709 |
| 16 | MP0002398_abnormal_bone_marrow | 2.29405607 |
| 17 | MP0002166_altered_tumor_susceptibility | 2.26420254 |
| 18 | MP0003763_abnormal_thymus_physiology | 2.22473163 |
| 19 | MP0002419_abnormal_innate_immunity | 2.22278482 |
| 20 | MP0005025_abnormal_response_to | 2.19795091 |
| 21 | MP0004808_abnormal_hematopoietic_stem | 2.15998110 |
| 22 | MP0000716_abnormal_immune_system | 2.07409493 |
| 23 | MP0005464_abnormal_platelet_physiology | 2.06666734 |
| 24 | MP0009785_altered_susceptibility_to | 2.05935807 |
| 25 | MP0002405_respiratory_system_inflammati | 1.99521283 |
| 26 | MP0000689_abnormal_spleen_morphology | 1.99191027 |
| 27 | MP0001873_stomach_inflammation | 1.97114105 |
| 28 | MP0002722_abnormal_immune_system | 1.89754672 |
| 29 | MP0003172_abnormal_lysosome_physiology | 1.86195608 |
| 30 | MP0001853_heart_inflammation | 1.85581946 |
| 31 | MP0006082_CNS_inflammation | 1.83593591 |
| 32 | MP0002148_abnormal_hypersensitivity_rea | 1.80726729 |
| 33 | MP0000465_gastrointestinal_hemorrhage | 1.79999144 |
| 34 | MP0002429_abnormal_blood_cell | 1.79411775 |
| 35 | MP0002933_joint_inflammation | 1.78991542 |
| 36 | MP0008438_abnormal_cutaneous_collagen | 1.78143543 |
| 37 | MP0003724_increased_susceptibility_to | 1.77756159 |
| 38 | MP0009278_abnormal_bone_marrow | 1.74735411 |
| 39 | MP0005058_abnormal_lysosome_morphology | 1.74480747 |
| 40 | MP0009333_abnormal_splenocyte_physiolog | 1.71309956 |
| 41 | MP0005397_hematopoietic_system_phenotyp | 1.69202654 |
| 42 | MP0001545_abnormal_hematopoietic_system | 1.69202654 |
| 43 | MP0010155_abnormal_intestine_physiology | 1.68999130 |
| 44 | MP0003279_aneurysm | 1.68857545 |
| 45 | MP0008260_abnormal_autophagy | 1.67577670 |
| 46 | MP0001542_abnormal_bone_strength | 1.65667771 |
| 47 | MP0004947_skin_inflammation | 1.63908103 |
| 48 | MP0002006_tumorigenesis | 1.61030527 |
| 49 | MP0005174_abnormal_tail_pigmentation | 1.57938851 |
| 50 | MP0000703_abnormal_thymus_morphology | 1.55282653 |
| 51 | MP0001845_abnormal_inflammatory_respons | 1.54130295 |
| 52 | MP0004510_myositis | 1.49788237 |
| 53 | MP0001533_abnormal_skeleton_physiology | 1.49219075 |
| 54 | MP0003566_abnormal_cell_adhesion | 1.47879910 |
| 55 | MP0010352_gastrointestinal_tract_polyps | 1.42800459 |
| 56 | MP0000604_amyloidosis | 1.32694063 |
| 57 | MP0003828_pulmonary_edema | 1.32509594 |
| 58 | MP0004883_abnormal_blood_vessel | 1.31052408 |
| 59 | MP0000858_altered_metastatic_potential | 1.27190504 |
| 60 | MP0005164_abnormal_response_to | 1.25176010 |
| 61 | MP0000490_abnormal_crypts_of | 1.23480664 |
| 62 | MP0003866_abnormal_defecation | 1.21476638 |
| 63 | MP0001958_emphysema | 1.20283125 |
| 64 | MP0005023_abnormal_wound_healing | 1.19498619 |
| 65 | MP0000343_altered_response_to | 1.19011357 |
| 66 | MP0000569_abnormal_digit_pigmentation | 1.17295000 |
| 67 | MP0005451_abnormal_body_composition | 1.16009561 |
| 68 | MP0008469_abnormal_protein_level | 1.14666780 |
| 69 | MP0005075_abnormal_melanosome_morpholog | 1.13709570 |
| 70 | MP0003448_altered_tumor_morphology | 1.12161241 |
| 71 | MP0003045_fibrosis | 1.07635697 |
| 72 | MP0003705_abnormal_hypodermis_morpholog | 1.07408518 |
| 73 | MP0005310_abnormal_salivary_gland | 1.05932844 |
| 74 | MP0010307_abnormal_tumor_latency | 0.99329496 |
| 75 | MP0005166_decreased_susceptibility_to | 0.99197080 |
| 76 | MP0003091_abnormal_cell_migration | 0.97639655 |
| 77 | MP0002877_abnormal_melanocyte_morpholog | 0.96388713 |
| 78 | MP0000767_abnormal_smooth_muscle | 0.95611037 |
| 79 | MP0008007_abnormal_cellular_replicative | 0.95441942 |
| 80 | MP0002998_abnormal_bone_remodeling | 0.95073037 |
| 81 | MP0001879_abnormal_lymphatic_vessel | 0.92837756 |
| 82 | MP0005257_abnormal_intraocular_pressure | 0.92465561 |
| 83 | MP0006054_spinal_hemorrhage | 0.90705918 |
| 84 | MP0002019_abnormal_tumor_incidence | 0.90163545 |
| 85 | MP0003191_abnormal_cellular_cholesterol | 0.88955424 |
| 86 | MP0005076_abnormal_cell_differentiation | 0.87821252 |
| 87 | MP0005390_skeleton_phenotype | 0.85230168 |
| 88 | MP0010368_abnormal_lymphatic_system | 0.83375002 |
| 89 | MP0002095_abnormal_skin_pigmentation | 0.83341396 |
| 90 | MP0003690_abnormal_glial_cell | 0.82383542 |
| 91 | MP0001851_eye_inflammation | 0.78691195 |
| 92 | MP0000015_abnormal_ear_pigmentation | 0.78641905 |
| 93 | MP0000249_abnormal_blood_vessel | 0.78570065 |
| 94 | MP0003183_abnormal_peptide_metabolism | 0.76594622 |
| 95 | MP0005165_increased_susceptibility_to | 0.74785715 |
| 96 | MP0003806_abnormal_nucleotide_metabolis | 0.74320754 |
| 97 | MP0001849_ear_inflammation | 0.72443105 |
| 98 | MP0000371_diluted_coat_color | 0.71564638 |
| 99 | MP0002254_reproductive_system_inflammat | 0.70457078 |
| 100 | MP0005595_abnormal_vascular_smooth | 0.70366920 |
| 101 | MP0008057_abnormal_DNA_replication | 0.69780327 |
| 102 | MP0001243_abnormal_dermal_layer | 0.69680300 |
| 103 | MP0003075_altered_response_to | 0.69431548 |
| 104 | MP0004858_abnormal_nervous_system | 0.69387392 |
| 105 | MP0002132_abnormal_respiratory_system | 0.69212253 |
| 106 | MP0009763_increased_sensitivity_to | 0.67965854 |
| 107 | MP0005275_abnormal_skin_tensile | 0.67567731 |
| 108 | MP0002928_abnormal_bile_duct | 0.67447861 |
| 109 | MP0009840_abnormal_foam_cell | 0.66704670 |
| 110 | MP0002060_abnormal_skin_morphology | 0.66398132 |
| 111 | MP0003795_abnormal_bone_structure | 0.66011215 |
| 112 | MP0005508_abnormal_skeleton_morphology | 0.65939866 |
| 113 | MP0000920_abnormal_myelination | 0.64661600 |
| 114 | MP0003077_abnormal_cell_cycle | 0.64327094 |
| 115 | MP0005503_abnormal_tendon_morphology | 0.63942380 |
| 116 | MP0009764_decreased_sensitivity_to | 0.63931272 |
| 117 | MP0009384_cardiac_valve_regurgitation | 0.61700925 |
| 118 | MP0005388_respiratory_system_phenotype | 0.61400077 |
| 119 | MP0002133_abnormal_respiratory_system | 0.61400077 |
| 120 | MP0000733_abnormal_muscle_development | 0.60756791 |
| 121 | MP0002128_abnormal_blood_circulation | 0.57631434 |
| 122 | MP0001663_abnormal_digestive_system | 0.57616697 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 4.42218918 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.42218918 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.42218918 |
| 4 | Chronic otitis media (HP:0000389) | 4.23887002 |
| 5 | Agammaglobulinemia (HP:0004432) | 4.21172381 |
| 6 | Recurrent abscess formation (HP:0002722) | 4.18106177 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.09645530 |
| 8 | IgM deficiency (HP:0002850) | 3.97410724 |
| 9 | Cellulitis (HP:0100658) | 3.91836438 |
| 10 | Recurrent viral infections (HP:0004429) | 3.80224469 |
| 11 | Recurrent bacterial skin infections (HP:0005406) | 3.73567399 |
| 12 | Myositis (HP:0100614) | 3.73424813 |
| 13 | Recurrent bronchitis (HP:0002837) | 3.71271791 |
| 14 | Inflammation of the large intestine (HP:0002037) | 3.67634718 |
| 15 | Colitis (HP:0002583) | 3.66011798 |
| 16 | Gastrointestinal inflammation (HP:0004386) | 3.61694948 |
| 17 | Thrombocytosis (HP:0001894) | 3.57670957 |
| 18 | Eczematoid dermatitis (HP:0000976) | 3.57012621 |
| 19 | Recurrent fungal infections (HP:0002841) | 3.56389475 |
| 20 | Spontaneous hematomas (HP:0007420) | 3.45626921 |
| 21 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.41613130 |
| 22 | Abnormality of the nasal mucosa (HP:0000433) | 3.37372693 |
| 23 | Panhypogammaglobulinemia (HP:0003139) | 3.33891239 |
| 24 | Nasal polyposis (HP:0100582) | 3.22953997 |
| 25 | Meningitis (HP:0001287) | 3.19861889 |
| 26 | Hematochezia (HP:0002573) | 3.18032903 |
| 27 | Gastrointestinal stroma tumor (HP:0100723) | 3.16537254 |
| 28 | Recurrent cutaneous fungal infections (HP:0011370) | 3.12102486 |
| 29 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.12102486 |
| 30 | Mediastinal lymphadenopathy (HP:0100721) | 3.04592806 |
| 31 | Recurrent skin infections (HP:0001581) | 3.04125319 |
| 32 | Emphysema (HP:0002097) | 2.95196736 |
| 33 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.95184193 |
| 34 | Protrusio acetabuli (HP:0003179) | 2.93170854 |
| 35 | Prolonged bleeding time (HP:0003010) | 2.88319511 |
| 36 | Petechiae (HP:0000967) | 2.86057947 |
| 37 | Cerebral aneurysm (HP:0004944) | 2.85552168 |
| 38 | Aortic aneurysm (HP:0004942) | 2.79288308 |
| 39 | Premature rupture of membranes (HP:0001788) | 2.77477427 |
| 40 | Lymphopenia (HP:0001888) | 2.67717861 |
| 41 | Loss of speech (HP:0002371) | 2.64790065 |
| 42 | Stomatitis (HP:0010280) | 2.64381035 |
| 43 | Vasculitis (HP:0002633) | 2.64044683 |
| 44 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.62295310 |
| 45 | Abnormality of T cell physiology (HP:0011840) | 2.61370903 |
| 46 | Spondylolisthesis (HP:0003302) | 2.58538449 |
| 47 | Gastrointestinal infarctions (HP:0005244) | 2.58069116 |
| 48 | Retrobulbar optic neuritis (HP:0100654) | 2.57776367 |
| 49 | Optic neuritis (HP:0100653) | 2.57776367 |
| 50 | Interstitial pulmonary disease (HP:0006530) | 2.56959641 |
| 51 | Pustule (HP:0200039) | 2.56920211 |
| 52 | Verrucae (HP:0200043) | 2.53707921 |
| 53 | Papilloma (HP:0012740) | 2.53707921 |
| 54 | Obstructive lung disease (HP:0006536) | 2.52310166 |
| 55 | Chronic obstructive pulmonary disease (HP:0006510) | 2.52310166 |
| 56 | Systemic lupus erythematosus (HP:0002725) | 2.50105551 |
| 57 | Purpura (HP:0000979) | 2.49588945 |
| 58 | Abnormality of T cells (HP:0002843) | 2.47545983 |
| 59 | Epistaxis (HP:0000421) | 2.44975821 |
| 60 | Aortic dissection (HP:0002647) | 2.43172950 |
| 61 | Impaired platelet aggregation (HP:0003540) | 2.41298055 |
| 62 | Abnormal platelet function (HP:0011869) | 2.41298055 |
| 63 | Amyloidosis (HP:0011034) | 2.40589475 |
| 64 | Abnormality of macrophages (HP:0004311) | 2.39707972 |
| 65 | Periodontitis (HP:0000704) | 2.38611040 |
| 66 | Dysostosis multiplex (HP:0000943) | 2.37936283 |
| 67 | Chest pain (HP:0100749) | 2.37045142 |
| 68 | Increased density of long bones (HP:0006392) | 2.36133345 |
| 69 | Peritonitis (HP:0002586) | 2.34100664 |
| 70 | Orchitis (HP:0100796) | 2.33735758 |
| 71 | Osteomyelitis (HP:0002754) | 2.32953664 |
| 72 | Abnormality of the fingertips (HP:0001211) | 2.31377807 |
| 73 | Arterial thrombosis (HP:0004420) | 2.30710091 |
| 74 | Chronic sinusitis (HP:0011109) | 2.29705578 |
| 75 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.25389506 |
| 76 | Abnormality of the peritoneum (HP:0002585) | 2.23856281 |
| 77 | Urticaria (HP:0001025) | 2.21848548 |
| 78 | Restrictive lung disease (HP:0002091) | 2.19481128 |
| 79 | Hepatosplenomegaly (HP:0001433) | 2.16362893 |
| 80 | Chronic diarrhea (HP:0002028) | 2.14809518 |
| 81 | Recurrent lower respiratory tract infections (HP:0002783) | 2.14348406 |
| 82 | Increased serum ferritin (HP:0003281) | 2.14288479 |
| 83 | Fatigue (HP:0012378) | 2.12341552 |
| 84 | Pulmonary infiltrates (HP:0002113) | 2.12239705 |
| 85 | Gingival bleeding (HP:0000225) | 2.10177119 |
| 86 | Recurrent sinusitis (HP:0011108) | 2.09115536 |
| 87 | Hemoptysis (HP:0002105) | 2.08891654 |
| 88 | T lymphocytopenia (HP:0005403) | 2.08604053 |
| 89 | Mucopolysacchariduria (HP:0008155) | 2.08557407 |
| 90 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.08557407 |
| 91 | Leukocytosis (HP:0001974) | 2.06490793 |
| 92 | Encephalitis (HP:0002383) | 2.05241416 |
| 93 | Increased cerebral lipofuscin (HP:0011813) | 2.04290630 |
| 94 | IgA deficiency (HP:0002720) | 2.03662391 |
| 95 | Abnormal platelet volume (HP:0011876) | 2.03427632 |
| 96 | Increased IgE level (HP:0003212) | 2.01744968 |
| 97 | Axonal loss (HP:0003447) | 2.01232515 |
| 98 | Abnormality of T cell number (HP:0011839) | 2.00817711 |
| 99 | Vacuolated lymphocytes (HP:0001922) | 2.00178662 |
| 100 | Joint stiffness (HP:0001387) | 1.99952034 |
| 101 | Skin ulcer (HP:0200042) | 1.99375248 |
| 102 | Gingivitis (HP:0000230) | 1.99207378 |
| 103 | Asymmetric septal hypertrophy (HP:0001670) | 1.97622535 |
| 104 | Hypergammaglobulinemia (HP:0010702) | 1.95962811 |
| 105 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.95538057 |
| 106 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.95538057 |
| 107 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.95538057 |
| 108 | Mitral valve prolapse (HP:0001634) | 1.95245644 |
| 109 | Vertebral compression fractures (HP:0002953) | 1.93285342 |
| 110 | Osteolytic defects of the hand bones (HP:0009699) | 1.92719893 |
| 111 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.92719893 |
| 112 | Cervical subluxation (HP:0003308) | 1.92296424 |
| 113 | Reticulocytopenia (HP:0001896) | 1.92257520 |
| 114 | Abnormality of B cell number (HP:0010975) | 1.91251394 |
| 115 | B lymphocytopenia (HP:0010976) | 1.91251394 |
| 116 | J-shaped sella turcica (HP:0002680) | 1.90867673 |
| 117 | Increased IgM level (HP:0003496) | 1.90699531 |
| 118 | Dilatation of the ascending aorta (HP:0005111) | 1.89332179 |
| 119 | Myocardial infarction (HP:0001658) | 1.89236466 |
| 120 | Autoimmune thrombocytopenia (HP:0001973) | 1.89051092 |
| 121 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.87858346 |
| 122 | Increased variability in muscle fiber diameter (HP:0003557) | 1.87462976 |
| 123 | Keratoconjunctivitis sicca (HP:0001097) | 1.87208111 |
| 124 | Recurrent pneumonia (HP:0006532) | 1.87000412 |
| 125 | Bicuspid aortic valve (HP:0001647) | 1.86537023 |
| 126 | Granulocytopenia (HP:0001913) | 1.86011675 |
| 127 | Glomerulopathy (HP:0100820) | 1.85159881 |
| 128 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.84872769 |
| 129 | Acrocyanosis (HP:0001063) | 1.84852700 |
| 130 | Polycythemia (HP:0001901) | 1.81650677 |
| 131 | Ankle contracture (HP:0006466) | 1.80208445 |
| 132 | Upper motor neuron abnormality (HP:0002127) | 1.79617835 |
| 133 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.79121850 |
| 134 | Increased connective tissue (HP:0009025) | 1.78642392 |
| 135 | Thin bony cortex (HP:0002753) | 1.77149283 |
| 136 | Episodic fever (HP:0001954) | 1.77072350 |
| 137 | Slender build (HP:0001533) | 1.77060382 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.65788017 |
| 2 | KIT | 2.82400425 |
| 3 | ERN1 | 2.76979652 |
| 4 | TGFBR2 | 2.76195792 |
| 5 | EEF2K | 2.75968503 |
| 6 | BLK | 2.73875547 |
| 7 | CSF1R | 2.54010597 |
| 8 | PRPF4B | 2.43087903 |
| 9 | TRIB3 | 2.42791539 |
| 10 | TYK2 | 2.27241100 |
| 11 | ZAP70 | 2.18432199 |
| 12 | JAK3 | 2.15200490 |
| 13 | MAP3K13 | 2.04225256 |
| 14 | TBK1 | 1.92652648 |
| 15 | BTK | 1.90631542 |
| 16 | FLT3 | 1.89219116 |
| 17 | PKN2 | 1.88289730 |
| 18 | STK10 | 1.88137931 |
| 19 | LRRK2 | 1.83890076 |
| 20 | MAP3K11 | 1.69128410 |
| 21 | TESK1 | 1.64153301 |
| 22 | TEC | 1.63563726 |
| 23 | SYK | 1.62875904 |
| 24 | JAK1 | 1.59090154 |
| 25 | MAP3K10 | 1.56993245 |
| 26 | MAP3K3 | 1.55441204 |
| 27 | IRAK4 | 1.51567513 |
| 28 | TXK | 1.49552214 |
| 29 | KDR | 1.47269855 |
| 30 | GRK6 | 1.46794720 |
| 31 | TTN | 1.46181927 |
| 32 | RIPK4 | 1.43421504 |
| 33 | CSK | 1.43146985 |
| 34 | IKBKB | 1.41395400 |
| 35 | ITK | 1.40765493 |
| 36 | PIM2 | 1.39312615 |
| 37 | LCK | 1.34671161 |
| 38 | HCK | 1.30774066 |
| 39 | TAOK3 | 1.28161722 |
| 40 | SCYL2 | 1.27423774 |
| 41 | FES | 1.26963747 |
| 42 | DDR2 | 1.26830577 |
| 43 | MAP2K3 | 1.24880027 |
| 44 | SIK2 | 1.24316649 |
| 45 | CDC42BPA | 1.23195981 |
| 46 | NME2 | 1.20926330 |
| 47 | TAOK2 | 1.17309672 |
| 48 | IKBKE | 1.17191558 |
| 49 | RPS6KA4 | 1.14278416 |
| 50 | LYN | 1.13867495 |
| 51 | MATK | 1.13633130 |
| 52 | MAP3K14 | 1.13356207 |
| 53 | MYLK | 1.13220761 |
| 54 | FGFR4 | 1.12692311 |
| 55 | TGFBR1 | 1.07450543 |
| 56 | EPHB1 | 1.06861071 |
| 57 | MAP3K6 | 1.04692453 |
| 58 | GRK7 | 1.01167768 |
| 59 | TAOK1 | 0.98745457 |
| 60 | IRAK3 | 0.97975535 |
| 61 | TIE1 | 0.95823496 |
| 62 | CAMK1D | 0.95389824 |
| 63 | PIM1 | 0.95001401 |
| 64 | SMG1 | 0.94139551 |
| 65 | PAK4 | 0.93740179 |
| 66 | CDK12 | 0.91505735 |
| 67 | MAP3K1 | 0.90705455 |
| 68 | SIK3 | 0.85724526 |
| 69 | MAP3K7 | 0.84803982 |
| 70 | SIK1 | 0.83167560 |
| 71 | PTK6 | 0.81500393 |
| 72 | MOS | 0.80252252 |
| 73 | MARK3 | 0.78500962 |
| 74 | LIMK1 | 0.77061104 |
| 75 | FGFR3 | 0.76962523 |
| 76 | CLK1 | 0.74656192 |
| 77 | CDK4 | 0.73297902 |
| 78 | PDPK1 | 0.73145954 |
| 79 | ABL2 | 0.71536758 |
| 80 | NEK2 | 0.69923652 |
| 81 | RIPK1 | 0.69850020 |
| 82 | PRKD2 | 0.67986574 |
| 83 | TRPM7 | 0.66957539 |
| 84 | CHUK | 0.66659643 |
| 85 | PIK3CG | 0.65365826 |
| 86 | RPS6KA2 | 0.64994876 |
| 87 | CAMKK2 | 0.64098309 |
| 88 | PDK1 | 0.63918775 |
| 89 | NLK | 0.61483323 |
| 90 | PTK2B | 0.60714565 |
| 91 | FGR | 0.60247726 |
| 92 | STK38 | 0.58520061 |
| 93 | MAPKAPK3 | 0.56948847 |
| 94 | CDK6 | 0.55754499 |
| 95 | JAK2 | 0.55719835 |
| 96 | BMPR2 | 0.55516559 |
| 97 | RPS6KB2 | 0.53832859 |
| 98 | PAK2 | 0.53121444 |
| 99 | ARAF | 0.52112108 |
| 100 | KSR2 | 0.50409800 |
| 101 | TNK2 | 0.50317463 |
| 102 | MAPK7 | 0.49976609 |
| 103 | CDK9 | 0.49712514 |
| 104 | EPHA3 | 0.48824710 |
| 105 | MAPK4 | 0.48743354 |
| 106 | DMPK | 0.47970768 |
| 107 | MAPK12 | 0.47680866 |
| 108 | FYN | 0.47580264 |
| 109 | PDGFRB | 0.47164497 |
| 110 | RAF1 | 0.45808299 |
| 111 | MAPKAPK2 | 0.44711014 |
| 112 | PRKG2 | 0.43083260 |
| 113 | PRKCQ | 0.42651972 |
| 114 | TESK2 | 0.42608415 |
| 115 | HIPK2 | 0.42553958 |
| 116 | CAMK1G | 0.42363289 |
| 117 | RPS6KA6 | 0.41869004 |
| 118 | MAP2K2 | 0.41097528 |
| 119 | CAMKK1 | 0.38974756 |
| 120 | MAPK11 | 0.36692334 |
| 121 | ABL1 | 0.36007690 |
| 122 | EGFR | 0.35913294 |
| 123 | MAP3K8 | 0.35866831 |
| 124 | PDGFRA | 0.35418350 |
| 125 | MARK2 | 0.34854983 |
| 126 | NEK9 | 0.33677228 |
| 127 | PRKD1 | 0.33533352 |
| 128 | RPS6KL1 | 0.33429033 |
| 129 | RPS6KC1 | 0.33429033 |
| 130 | STK4 | 0.33266196 |
| 131 | ADRBK2 | 0.32606865 |
| 132 | PRKCH | 0.32555875 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.34373381 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 3.22130410 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.60231163 |
| 4 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.45938041 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.27428022 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.27004228 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.23365227 |
| 8 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.14466803 |
| 9 | Measles_Homo sapiens_hsa05162 | 2.06455064 |
| 10 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.98045934 |
| 11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.97884953 |
| 12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.91324935 |
| 13 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.83767519 |
| 14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.80867923 |
| 15 | Other glycan degradation_Homo sapiens_hsa00511 | 1.74046586 |
| 16 | DNA replication_Homo sapiens_hsa03030 | 1.70494195 |
| 17 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.69339153 |
| 18 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.67587081 |
| 19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.67168203 |
| 20 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.66493891 |
| 21 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.58342993 |
| 22 | Pertussis_Homo sapiens_hsa05133 | 1.56512703 |
| 23 | Shigellosis_Homo sapiens_hsa05131 | 1.55246728 |
| 24 | Ribosome_Homo sapiens_hsa03010 | 1.54918576 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.52832722 |
| 26 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.48904169 |
| 27 | Malaria_Homo sapiens_hsa05144 | 1.48497829 |
| 28 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.46949232 |
| 29 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.45907441 |
| 30 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.45800298 |
| 31 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.44007896 |
| 32 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.42965500 |
| 33 | Platelet activation_Homo sapiens_hsa04611 | 1.42116880 |
| 34 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.40750742 |
| 35 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.39961031 |
| 36 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.39004690 |
| 37 | Base excision repair_Homo sapiens_hsa03410 | 1.37310277 |
| 38 | Tuberculosis_Homo sapiens_hsa05152 | 1.37281733 |
| 39 | Apoptosis_Homo sapiens_hsa04210 | 1.35467327 |
| 40 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.33777164 |
| 41 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.33239461 |
| 42 | Hepatitis B_Homo sapiens_hsa05161 | 1.30652766 |
| 43 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.23405037 |
| 44 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.19258965 |
| 45 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.18045764 |
| 46 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.16676732 |
| 47 | Influenza A_Homo sapiens_hsa05164 | 1.16381013 |
| 48 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.16041218 |
| 49 | Lysosome_Homo sapiens_hsa04142 | 1.12977746 |
| 50 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.11650539 |
| 51 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.10279455 |
| 52 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.09094552 |
| 53 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.08643278 |
| 54 | Viral myocarditis_Homo sapiens_hsa05416 | 1.08441763 |
| 55 | Legionellosis_Homo sapiens_hsa05134 | 1.04075209 |
| 56 | Mismatch repair_Homo sapiens_hsa03430 | 1.00262262 |
| 57 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.99115481 |
| 58 | HTLV-I infection_Homo sapiens_hsa05166 | 0.98852482 |
| 59 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.95903885 |
| 60 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.93555041 |
| 61 | Allograft rejection_Homo sapiens_hsa05330 | 0.93065011 |
| 62 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.92901841 |
| 63 | Salmonella infection_Homo sapiens_hsa05132 | 0.92042280 |
| 64 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.91715247 |
| 65 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.91259675 |
| 66 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.91192172 |
| 67 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.85149497 |
| 68 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.83407762 |
| 69 | Colorectal cancer_Homo sapiens_hsa05210 | 0.80798712 |
| 70 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.80415885 |
| 71 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.80336061 |
| 72 | Bladder cancer_Homo sapiens_hsa05219 | 0.78935962 |
| 73 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.75886628 |
| 74 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.74114385 |
| 75 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.71862546 |
| 76 | Focal adhesion_Homo sapiens_hsa04510 | 0.71264027 |
| 77 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.71012682 |
| 78 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.69985335 |
| 79 | Prion diseases_Homo sapiens_hsa05020 | 0.69320915 |
| 80 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.69006363 |
| 81 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.68374146 |
| 82 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.67160356 |
| 83 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.66869395 |
| 84 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.63576578 |
| 85 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.62611705 |
| 86 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.60784018 |
| 87 | Homologous recombination_Homo sapiens_hsa03440 | 0.58818967 |
| 88 | Hepatitis C_Homo sapiens_hsa05160 | 0.57594092 |
| 89 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.56890880 |
| 90 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.55138399 |
| 91 | Amoebiasis_Homo sapiens_hsa05146 | 0.53736806 |
| 92 | Galactose metabolism_Homo sapiens_hsa00052 | 0.53103329 |
| 93 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.52810112 |
| 94 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51927434 |
| 95 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.50151949 |
| 96 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.49551080 |
| 97 | Insulin resistance_Homo sapiens_hsa04931 | 0.47746008 |
| 98 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.47731958 |
| 99 | Lysine degradation_Homo sapiens_hsa00310 | 0.46167209 |
| 100 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.45929544 |
| 101 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.44720523 |
| 102 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.44391544 |
| 103 | Asthma_Homo sapiens_hsa05310 | 0.43519549 |
| 104 | Pathways in cancer_Homo sapiens_hsa05200 | 0.43353945 |
| 105 | Endocytosis_Homo sapiens_hsa04144 | 0.42953024 |
| 106 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.42438623 |
| 107 | Spliceosome_Homo sapiens_hsa03040 | 0.42426447 |
| 108 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.42176301 |
| 109 | Adherens junction_Homo sapiens_hsa04520 | 0.40954530 |
| 110 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37933388 |
| 111 | Glioma_Homo sapiens_hsa05214 | 0.36805845 |
| 112 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.34613652 |
| 113 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.32990107 |
| 114 | Phagosome_Homo sapiens_hsa04145 | 0.32450890 |
| 115 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.31893126 |
| 116 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.31882581 |
| 117 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.31626802 |
| 118 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.31625813 |
| 119 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.31172575 |
| 120 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.30816639 |
| 121 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.30400093 |
| 122 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.30326035 |

